Celsion Corporation Stock Nasdaq
Equities
US15117N3052
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 20 | Imunon, Inc. Announces CFO Changes, Effective from June 1, 2024 | CI |
May. 13 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.82M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -25M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-0.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Celsion Corporation
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 21-06-03 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-09-02 |
1st Jan change | Capi. | |
---|---|---|
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.51% | 21.83B | |
-10.67% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |